Skip to main content
All lobbying filings

Thorn Run Partners

Thorn Run Partners filed a Q3 report for Pharmaceutical Research and Manufacturers of America on October 20, 2026, reporting $40,000 in lobbying income.

Lobbying for Pharmaceutical Research and Manufacturers of America · Pharmaceutical Industry Association

As filed: THORN RUN PARTNERS for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA.

All filings by Thorn Run Partners · Everything Pharmaceutical Research and Manufacturers of America has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 20, 2026
Income
$40,000
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Lobbyists on this filing 2
  • BEAU SCHUYLER
    Previously held: Legislative Director: Rep. Tanner; Legislative Director: Rep. McIntyre
  • YUL EDWARDS
    Previously held: Legislative Assistant/Chief of Staff, Rep. Danny K. Davis; Legislative Director, Rep. Frank Ballance, Jr.

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1

Promoting pharmaceutical research and development and ensuring access to medicines.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem